Thromboelastography (TEG) In the Intrauterine Growth Restriction (IUGR) Neonatal Population by Gestational Age

NCT04907578 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-08-18

No results posted yet for this study

Summary

The investigators aim to improve the understanding of TEG in this population in an effort to improve outcomes in a population at high risk in both the presence and absence of blood product transfusions.

Conditions

  • Intrauterine Growth Restriction

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Jonathan H. Waters, MD · University of Pittsburgh

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-12
Primary Completion
2021-08-12
Completion
2021-08-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04907578 on ClinicalTrials.gov